A combination therapy with low dose desmopressin and tolterodine improves health-related quality of life in female patients with overactive bladder and nocturnal polyuria

Andersson F1, Raymond K1, Vinter Juul K1, Rosen R2

Research Type

Clinical

Abstract Category

Nocturia

Abstract 35
Nocturia/Male LUTS
Scientific Podium Short Oral Session 5
Wednesday 7th October 2015
11:00 - 11:07
210BC
Nocturia Quality of Life (QoL) Questionnaire Female Clinical Trial
1. Ferring Pharmaceuticals, Kay Fiskers Plads 11 Copenhagen S, Denmark, 2. New England Research Institutes, Inc., Watertown, MA, USA
Presenter
K

Kristian Vinter Juul
Ferring Pharmaceuticals, Kay Fiskers Plads 11 Copenhagen S, Denmark
Links

Abstract

20/11/2024 08:03:04